Virginia Tech
    • Log in
    View Item 
    •   VTechWorks Home
    • Destination Areas (DAs) and Strategic Growth Areas (SGAs)
    • Destination Areas (DAs)
    • Destination Area: Data and Decisions (D&D)
    • View Item
    •   VTechWorks Home
    • Destination Areas (DAs) and Strategic Growth Areas (SGAs)
    • Destination Areas (DAs)
    • Destination Area: Data and Decisions (D&D)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid

    Thumbnail
    View/Open
    SettlageMarksofAlzheimers2015.pdf (469.7Kb)
    Downloads: 138
    Date
    2015-08-13
    Author
    Hendrickson, Ronald C.
    Lee, Anita Y.H.
    Song, Qinghua
    Liaw, Andy
    Winer, Matt
    Paweletz, Cloud P.
    Seeburger, Jeffrey L.
    Li, Jenny
    Meng, Fanyu
    Deyanova, Ekaterina G.
    Mazur, Matthew T.
    Settlage, Robert E.
    Zhao, Xuemei
    Southwick, Katie
    Du, Yi
    Holder, Dan
    Sachs, Jeffrey R.
    Laterza, Omar F.
    Dallob, Aimee
    Chappell, Derek L.
    Snyder, Karen
    Modur, Vijay
    King, Elizabeth
    Joachim, Catharine
    Bondarenko, Andrey Y.
    Shearman, Mark
    Soper, Keith A.
    Smith, A. David
    Potter, William Z.
    Koblan, Ken S.
    Sachs, Alan B.
    Yates, Nathan A.
    Metadata
    Show full item record
    Abstract
    Disease modifying treatments for Alzheimer’s disease (AD) constitute a major goal in medicine. Current trends suggest that biomarkers reflective of AD neuropathology and modifiable by treatment would provide supportive evidence for disease modification. Nevertheless, a lack of quantitative tools to assess disease modifying treatment effects remains a major hurdle. Cerebrospinal fluid (CSF) biochemical markers such as total tau, p-tau and Ab42 are well established markers of AD; however, global quantitative biochemical changes in CSF in AD disease progression remain largely uncharacterized. Here we applied a high resolution open discovery platform, dMS, to profile a cross-sectional cohort of lumbar CSF from post-mortem diagnosed AD patients versus those from non-AD/non-demented (control) patients. Multiple markers were identified to be statistically significant in the cohort tested. We selected two markers SME-1 (p<0.0001) and SME-2 (p = 0.0004) for evaluation in a second independent longitudinal cohort of human CSF from post-mortem diagnosed AD patients and age-matched and case-matched control patients. In cohort-2, SME-1, identified as neuronal secretory protein VGF, and SME-2, identified as neuronal pentraxin receptor-1 (NPTXR), in AD were 21% (p = 0.039) and 17% (p = 0.026) lower, at baseline, respectively, than in controls. Linear mixed model analysis in the longitudinal cohort estimate a decrease in the levels of VGF and NPTXR at the rate of 10.9% and 6.9% per year in the AD patients, whereas both markers increased in controls. Because these markers are detected by mass spectrometry without the need for antibody reagents, targeted MS based assays provide a clear translation path for evaluating selected AD disease-progression markers with high analytical precision in the clinic.
    URI
    http://hdl.handle.net/10919/79914
    Collections
    • Destination Area: Data and Decisions (D&D) [132]
    • Scholarly Works, Fralin Life Sciences Institute [495]

    If you believe that any material in VTechWorks should be removed, please see our policy and procedure for Requesting that Material be Amended or Removed. All takedown requests will be promptly acknowledged and investigated.

    Virginia Tech | University Libraries | Contact Us
     

     

    VTechWorks

    AboutPoliciesHelp

    Browse

    All of VTechWorksCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Log inRegister

    Statistics

    View Usage Statistics

    If you believe that any material in VTechWorks should be removed, please see our policy and procedure for Requesting that Material be Amended or Removed. All takedown requests will be promptly acknowledged and investigated.

    Virginia Tech | University Libraries | Contact Us